Literature DB >> 30763987

Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease

Gül Sema Keskin, Özant Helvacı, Çağrı Yayla, Özge Paşaoğlu, Çağlar Keskin, Turgay Arınsoy, Ülver Derici.   

Abstract

Background/aim: We aimed to evaluate the relationship between YKL-40 and endothelial dysfunction in chronic kidney disease. Materials and methods: Twenty-nine hemodialysis patients, 101 patients with nondialytic (stage 2, 3, 4, and 5 ND) chronic kidney disease (CKD), and 38 healthy individuals as a control group were included. YKL-40 levels were measured by ELISA. Endothelial dysfunction was indirectly measured by flow-mediated dilatation percentage (FMD) in the brachial artery. YKL-40 levels were higher in CKD patients than controls and highest in HD patients (P = 0.001). FMD values were lower in nondialytic CKD patients and lowest in HD patients (P = 0.001). YKL-40 negatively correlated with eGFR and FMD values (r = –0.674 and r = –0.471, respectively). This study shows that YKL-40 increases with CKD stage and is negatively correlated with FMD measurements

Entities:  

Keywords:  YKL-40; CKD; hemodialysis; atherosclerosis; endothelial dysfunction

Mesh:

Substances:

Year:  2019        PMID: 30763987     DOI: 10.3906/sag-1804-169

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  1 in total

1.  The new marker YKL-40, a molecule related to inflammation, is associated with cardiovascular events in stable haemodialysis patients.

Authors:  Almudena Vega; Maria Dolores Sanchez-Niño; Alberto Ortiz; Soraya Abad; Nicolás Macías; Inés Aragoncillo; Alba Santos; Ana García-Prieto; Esther Torres; Andrés Hernández; Luis Sánchez-Cámara; Esther Hurtado; Lara Valiño-Rivas; José Luño
Journal:  Clin Kidney J       Date:  2019-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.